Stage IV: Using this system,
outcomes are best for patients with early stages of disease, with small tumours, no spread to lymph nodes, and no distant spread (metastasis) to other organs. Outcomes are also better for younger patients. Overall, despite treatment, 5-year survival for all types of lung cancer is not good: 11% for males and 14% for females.